HK Stock Market Move | LYGEND RESOURCE (02245) rises over 5%, A+H listing imminent, net profit for the first three quarters expected to increase over 54%.
Lygend Resource (02245) rose over 5%. As of press time, it was up 5.69% at HK$17.64, with a turnover of HK$63.8859 million.
LYGEND RESOURCE (02245) rose over 5%, up 5.69% as of press time, at HK$17.64, with a turnover of HK$63.8859 million.
On the news front, on September 10, LYGEND RESOURCE disclosed its prospectus for the initial public offering and listing on the Main Board, officially launching its Shenzhen Main Board issuance, with the subscription date set for September 18. LYGEND RESOURCE stated that the company was listed on the Hong Kong Stock Exchange in December 2022, and this financing on the Shenzhen Stock Exchange will help the company leverage the respective advantages of the two capital markets, broaden financing channels, optimize its financing structure, enhance its core competitiveness and risk resistance, and provide strong support for the company to deepen its business layout in the nickel industry in Indonesia and other "Belt and Road" regions.
The prospectus shows that, benefiting from the recovery in nickel prices, the gradual release of newly built smelting capacity, and the continued expansion of downstream market demand, LYGEND RESOURCE expects its operating revenue for the first three quarters of 2026 to be RMB 38 billion to RMB 42 billion, a year-on-year increase of 27.93% to 41.40%; net profit attributable to the parent company to be RMB 3.150 billion to RMB 3.250 billion, a year-on-year increase of 54.00% to 58.89%.
Related Articles

HK Stock Market Move | SMC ELECTRIC (02381) surged over 25% again, doubling its share price within the month; Star Mega Holdings completed the acquisition of a 70% stake in the company.

Tianjin Tianyao Pharmaceuticals (600488.SH) subsidiary obtains drug registration certificate for Bupivacaine Hydrochloride Injection.

New Stock Preview | Overcoming the challenge of antibiotic resistance, can Prolyse Pharmaceuticals' bid for a Hong Kong listing win a bet from the market?
HK Stock Market Move | SMC ELECTRIC (02381) surged over 25% again, doubling its share price within the month; Star Mega Holdings completed the acquisition of a 70% stake in the company.

Tianjin Tianyao Pharmaceuticals (600488.SH) subsidiary obtains drug registration certificate for Bupivacaine Hydrochloride Injection.

New Stock Preview | Overcoming the challenge of antibiotic resistance, can Prolyse Pharmaceuticals' bid for a Hong Kong listing win a bet from the market?

RECOMMEND





